nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—sarcoma	0.593	1	CbGaD
Acetylsalicylic acid—PTGS2—Etoposide—sarcoma	0.026	0.23	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—sarcoma	0.0219	0.194	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—sarcoma	0.0152	0.134	CbGbCtD
Acetylsalicylic acid—ABCB1—Mitoxantrone—sarcoma	0.0136	0.12	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—sarcoma	0.0127	0.112	CbGbCtD
Acetylsalicylic acid—ABCB1—Vincristine—sarcoma	0.00935	0.0827	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—sarcoma	0.00857	0.0758	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—sarcoma	0.00584	0.0517	CbGbCtD
Acetylsalicylic acid—TP53—larynx—sarcoma	0.0051	0.0479	CbGeAlD
Acetylsalicylic acid—TP53—skull—sarcoma	0.00456	0.0429	CbGeAlD
Acetylsalicylic acid—TP53—forelimb—sarcoma	0.0044	0.0413	CbGeAlD
Acetylsalicylic acid—TP53—arm—sarcoma	0.00378	0.0355	CbGeAlD
Acetylsalicylic acid—HSPA5—cartilage tissue—sarcoma	0.00375	0.0352	CbGeAlD
Acetylsalicylic acid—TP53—appendage—sarcoma	0.00339	0.0319	CbGeAlD
Acetylsalicylic acid—TP53—manus—sarcoma	0.00336	0.0316	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—sarcoma	0.00329	0.0309	CbGeAlD
Acetylsalicylic acid—TP53—endothelium—sarcoma	0.00205	0.0192	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—sarcoma	0.00201	0.0189	CbGeAlD
Acetylsalicylic acid—TP53—mammary gland—sarcoma	0.00165	0.0155	CbGeAlD
Acetylsalicylic acid—HSPA5—mammary gland—sarcoma	0.00159	0.0149	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammary gland—sarcoma	0.00135	0.0127	CbGeAlD
Acetylsalicylic acid—TP53—myometrium—sarcoma	0.00117	0.011	CbGeAlD
Acetylsalicylic acid—NFKBIA—myometrium—sarcoma	0.00115	0.0108	CbGeAlD
Acetylsalicylic acid—Metabolic acidosis—Etoposide—sarcoma	0.00113	0.0262	CcSEcCtD
Acetylsalicylic acid—HSPA5—myometrium—sarcoma	0.00113	0.0106	CbGeAlD
Acetylsalicylic acid—TP53—embryo—sarcoma	0.00113	0.0106	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—sarcoma	0.00111	0.0104	CbGeAlD
Acetylsalicylic acid—EDNRA—mammary gland—sarcoma	0.0011	0.0103	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—sarcoma	0.00109	0.0102	CbGeAlD
Acetylsalicylic acid—PTGS2—periosteum—sarcoma	0.00107	0.0101	CbGeAlD
Acetylsalicylic acid—NFKBIA—seminal vesicle—sarcoma	0.00104	0.00978	CbGeAlD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—sarcoma	0.00103	0.247	CbGdCrCtD
Acetylsalicylic acid—HSPA5—seminal vesicle—sarcoma	0.00102	0.00958	CbGeAlD
Acetylsalicylic acid—TP53—hematopoietic system—sarcoma	0.00101	0.00944	CbGeAlD
Acetylsalicylic acid—Eruption—Dactinomycin—sarcoma	0.001	0.0233	CcSEcCtD
Acetylsalicylic acid—NFKBIA—hematopoietic system—sarcoma	0.000989	0.00929	CbGeAlD
Acetylsalicylic acid—HSPA5—hematopoietic system—sarcoma	0.000969	0.0091	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—sarcoma	0.000968	0.00909	CbGeAlD
Acetylsalicylic acid—RPS6KA3—myometrium—sarcoma	0.000961	0.00903	CbGeAlD
Acetylsalicylic acid—NFKBIA—connective tissue—sarcoma	0.000953	0.00895	CbGeAlD
Acetylsalicylic acid—HSPA5—connective tissue—sarcoma	0.000933	0.00876	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—sarcoma	0.000925	0.00868	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—sarcoma	0.000886	0.00832	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—sarcoma	0.000874	0.00821	CbGeAlD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—sarcoma	0.000871	0.00818	CbGeAlD
Acetylsalicylic acid—RPS6KA3—seminal vesicle—sarcoma	0.000868	0.00816	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—sarcoma	0.00086	0.00808	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—sarcoma	0.000853	0.00802	CbGeAlD
Acetylsalicylic acid—PTGS2—leg—sarcoma	0.000853	0.00801	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—sarcoma	0.000842	0.00791	CbGeAlD
Acetylsalicylic acid—RPS6KA3—hematopoietic system—sarcoma	0.000825	0.00775	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Dactinomycin—sarcoma	0.0008	0.0186	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—connective tissue—sarcoma	0.000795	0.00746	CbGeAlD
Acetylsalicylic acid—Coagulopathy—Dactinomycin—sarcoma	0.000793	0.0184	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—sarcoma	0.000783	0.188	CbGdCrCtD
Acetylsalicylic acid—EDNRA—myometrium—sarcoma	0.000781	0.00734	CbGeAlD
Acetylsalicylic acid—PTGS2—hindlimb—sarcoma	0.000762	0.00716	CbGeAlD
Acetylsalicylic acid—TP53—uterus—sarcoma	0.00076	0.00713	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiac atrium—sarcoma	0.000751	0.00706	CbGeAlD
Acetylsalicylic acid—PTGS2—cartilage tissue—sarcoma	0.00075	0.00704	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—sarcoma	0.000747	0.00702	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiac atrium—sarcoma	0.000736	0.00691	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—sarcoma	0.000732	0.00687	CbGeAlD
Acetylsalicylic acid—IKBKB—myometrium—sarcoma	0.00071	0.00666	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—sarcoma	0.000708	0.00665	CbGeAlD
Acetylsalicylic acid—EDNRA—seminal vesicle—sarcoma	0.000706	0.00663	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—sarcoma	0.000697	0.00654	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—sarcoma	0.000683	0.00641	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—sarcoma	0.000682	0.00641	CbGeAlD
Acetylsalicylic acid—TP53—tendon—sarcoma	0.000666	0.00625	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—sarcoma	0.000655	0.00615	CbGeAlD
Acetylsalicylic acid—PTGS2—appendage—sarcoma	0.000654	0.00614	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Thiotepa—sarcoma	0.000654	0.0152	CcSEcCtD
Acetylsalicylic acid—Ulcer—Dactinomycin—sarcoma	0.000653	0.0152	CcSEcCtD
Acetylsalicylic acid—TP53—bone marrow—sarcoma	0.000645	0.00605	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—sarcoma	0.000641	0.00602	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—sarcoma	0.000634	0.00596	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiac atrium—sarcoma	0.000627	0.00589	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—sarcoma	0.000623	0.00586	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—sarcoma	0.000621	0.00583	CbGeAlD
Acetylsalicylic acid—Contusion—Mitoxantrone—sarcoma	0.000616	0.0143	CcSEcCtD
Acetylsalicylic acid—IKBKB—hematopoietic system—sarcoma	0.000609	0.00572	CbGeAlD
Acetylsalicylic acid—IKBKB—connective tissue—sarcoma	0.000587	0.00551	CbGeAlD
Acetylsalicylic acid—ALB—mammary gland—sarcoma	0.000584	0.00548	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—sarcoma	0.000581	0.00546	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Etoposide—sarcoma	0.000579	0.0134	CcSEcCtD
Acetylsalicylic acid—Ulcer—Mitoxantrone—sarcoma	0.000568	0.0132	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Vincristine—sarcoma	0.000562	0.013	CcSEcCtD
Acetylsalicylic acid—TP53—testis—sarcoma	0.000551	0.00518	CbGeAlD
Acetylsalicylic acid—RPS6KA3—tendon—sarcoma	0.000546	0.00513	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—sarcoma	0.000542	0.00509	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—sarcoma	0.000537	0.00504	CbGeAlD
Acetylsalicylic acid—HSPA5—testis—sarcoma	0.000531	0.00499	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—sarcoma	0.00053	0.00498	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—sarcoma	0.000529	0.00497	CbGeAlD
Acetylsalicylic acid—TP53—liver—sarcoma	0.000521	0.00489	CbGeAlD
Acetylsalicylic acid—Kidney function abnormal—Epirubicin—sarcoma	0.000518	0.012	CcSEcCtD
Acetylsalicylic acid—NFKBIA—liver—sarcoma	0.000513	0.00481	CbGeAlD
Acetylsalicylic acid—EDNRA—cardiac atrium—sarcoma	0.000509	0.00479	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—sarcoma	0.000507	0.00476	CbGeAlD
Acetylsalicylic acid—Chest discomfort—Etoposide—sarcoma	0.000505	0.0117	CcSEcCtD
Acetylsalicylic acid—Deafness—Thiotepa—sarcoma	0.000505	0.0117	CcSEcCtD
Acetylsalicylic acid—Coma—Vincristine—sarcoma	0.000504	0.0117	CcSEcCtD
Acetylsalicylic acid—HSPA5—liver—sarcoma	0.000502	0.00472	CbGeAlD
Acetylsalicylic acid—Kidney function abnormal—Doxorubicin—sarcoma	0.00048	0.0111	CcSEcCtD
Acetylsalicylic acid—Ulcer—Etoposide—sarcoma	0.000472	0.011	CcSEcCtD
Acetylsalicylic acid—IKBKB—uterus—sarcoma	0.00046	0.00432	CbGeAlD
Acetylsalicylic acid—Polyuria—Vincristine—sarcoma	0.000456	0.0106	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—testis—sarcoma	0.000452	0.00425	CbGeAlD
Acetylsalicylic acid—Deafness—Vincristine—sarcoma	0.000448	0.0104	CcSEcCtD
Acetylsalicylic acid—EDNRA—tendon—sarcoma	0.000444	0.00417	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—sarcoma	0.000429	0.00403	CbGeAlD
Acetylsalicylic acid—RPS6KA3—liver—sarcoma	0.000428	0.00402	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—sarcoma	0.000413	0.00388	CbGeAlD
Acetylsalicylic acid—CYP2C8—mammary gland—sarcoma	0.00041	0.00385	CbGeAlD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—sarcoma	0.000409	0.0978	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—sarcoma	0.000409	0.0978	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—sarcoma	0.000409	0.0978	CbGdCrCtD
Acetylsalicylic acid—Eruption—Epirubicin—sarcoma	0.000407	0.00945	CcSEcCtD
Acetylsalicylic acid—IKBKB—tendon—sarcoma	0.000403	0.00379	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—sarcoma	0.000399	0.00375	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—sarcoma	0.000395	0.00371	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—sarcoma	0.000393	0.00369	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00039	0.00905	CcSEcCtD
Acetylsalicylic acid—HSPA5—lymph node—sarcoma	0.000385	0.00362	CbGeAlD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—sarcoma	0.000378	0.0905	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—sarcoma	0.000378	0.0905	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—sarcoma	0.000378	0.0905	CbGdCrCtD
Acetylsalicylic acid—Eruption—Doxorubicin—sarcoma	0.000377	0.00875	CcSEcCtD
Acetylsalicylic acid—EDNRA—testis—sarcoma	0.000368	0.00345	CbGeAlD
Acetylsalicylic acid—CYP2C9—mammary gland—sarcoma	0.000364	0.00342	CbGeAlD
Acetylsalicylic acid—Haematemesis—Epirubicin—sarcoma	0.000361	0.00837	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Mitoxantrone—sarcoma	0.000355	0.00824	CcSEcCtD
Acetylsalicylic acid—IKBKB—testis—sarcoma	0.000334	0.00314	CbGeAlD
Acetylsalicylic acid—Haematemesis—Doxorubicin—sarcoma	0.000334	0.00774	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—lymph node—sarcoma	0.000328	0.00308	CbGeAlD
Acetylsalicylic acid—SLC22A7—testis—sarcoma	0.000324	0.00304	CbGeAlD
Acetylsalicylic acid—IKBKB—liver—sarcoma	0.000316	0.00296	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Thiotepa—sarcoma	0.000314	0.00729	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Thiotepa—sarcoma	0.000312	0.00725	CcSEcCtD
Acetylsalicylic acid—SLC22A7—liver—sarcoma	0.000306	0.00288	CbGeAlD
Acetylsalicylic acid—Drowsiness—Mitoxantrone—sarcoma	0.000301	0.00698	CcSEcCtD
Acetylsalicylic acid—Sweating—Vincristine—sarcoma	0.000296	0.00687	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Thiotepa—sarcoma	0.000291	0.00676	CcSEcCtD
Acetylsalicylic acid—Sweating—Mitoxantrone—sarcoma	0.000288	0.00669	CcSEcCtD
Acetylsalicylic acid—Flushing—Dactinomycin—sarcoma	0.000288	0.00668	CcSEcCtD
Acetylsalicylic acid—CYP2C19—hematopoietic system—sarcoma	0.000286	0.00269	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Mitoxantrone—sarcoma	0.000271	0.00629	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Mitoxantrone—sarcoma	0.00027	0.00626	CcSEcCtD
Acetylsalicylic acid—EDNRA—lymph node—sarcoma	0.000267	0.0025	CbGeAlD
Acetylsalicylic acid—Ulcer—Epirubicin—sarcoma	0.000265	0.00615	CcSEcCtD
Acetylsalicylic acid—Anaemia—Thiotepa—sarcoma	0.000251	0.00583	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—sarcoma	0.00025	0.00581	CcSEcCtD
Acetylsalicylic acid—CYP2C8—hematopoietic system—sarcoma	0.00025	0.00235	CbGeAlD
Acetylsalicylic acid—Agitation—Thiotepa—sarcoma	0.00025	0.0058	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—sarcoma	0.000249	0.00579	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—sarcoma	0.000245	0.00569	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—sarcoma	0.000245	0.00568	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Thiotepa—sarcoma	0.000243	0.00565	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymph node—sarcoma	0.000242	0.00227	CbGeAlD
Acetylsalicylic acid—Leukopenia—Dactinomycin—sarcoma	0.000242	0.00561	CcSEcCtD
Acetylsalicylic acid—Convulsion—Thiotepa—sarcoma	0.000236	0.00547	CcSEcCtD
Acetylsalicylic acid—Hypertension—Thiotepa—sarcoma	0.000235	0.00545	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—sarcoma	0.000232	0.00538	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Thiotepa—sarcoma	0.000232	0.00537	CcSEcCtD
Acetylsalicylic acid—Coma—Epirubicin—sarcoma	0.000229	0.00531	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—sarcoma	0.000226	0.00525	CcSEcCtD
Acetylsalicylic acid—PTGS2—myometrium—sarcoma	0.000226	0.00212	CbGeAlD
Acetylsalicylic acid—Confusional state—Thiotepa—sarcoma	0.000224	0.00519	CcSEcCtD
Acetylsalicylic acid—Anaemia—Vincristine—sarcoma	0.000223	0.00517	CcSEcCtD
Acetylsalicylic acid—CYP2C9—hematopoietic system—sarcoma	0.000222	0.00209	CbGeAlD
Acetylsalicylic acid—Agitation—Vincristine—sarcoma	0.000222	0.00514	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Thiotepa—sarcoma	0.000217	0.00504	CcSEcCtD
Acetylsalicylic acid—Anaemia—Mitoxantrone—sarcoma	0.000217	0.00504	CcSEcCtD
Acetylsalicylic acid—PTGS2—embryo—sarcoma	0.000217	0.00204	CbGeAlD
Acetylsalicylic acid—Vertigo—Vincristine—sarcoma	0.000217	0.00503	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Thiotepa—sarcoma	0.000217	0.00503	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Vincristine—sarcoma	0.000216	0.00501	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—sarcoma	0.000216	0.00501	CcSEcCtD
Acetylsalicylic acid—PTGS1—seminal vesicle—sarcoma	0.000213	0.002	CbGeAlD
Acetylsalicylic acid—Coma—Doxorubicin—sarcoma	0.000212	0.00492	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mitoxantrone—sarcoma	0.00021	0.00488	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—sarcoma	0.000209	0.00485	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vincristine—sarcoma	0.000209	0.00485	CcSEcCtD
Acetylsalicylic acid—Flushing—Etoposide—sarcoma	0.000208	0.00483	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vincristine—sarcoma	0.000208	0.00483	CcSEcCtD
Acetylsalicylic acid—PTGS2—seminal vesicle—sarcoma	0.000204	0.00191	CbGeAlD
Acetylsalicylic acid—Convulsion—Mitoxantrone—sarcoma	0.000203	0.00472	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Epirubicin—sarcoma	0.000203	0.00472	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mitoxantrone—sarcoma	0.000203	0.00471	CcSEcCtD
Acetylsalicylic acid—PTGS1—hematopoietic system—sarcoma	0.000203	0.0019	CbGeAlD
Acetylsalicylic acid—Chest pain—Mitoxantrone—sarcoma	0.0002	0.00464	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mitoxantrone—sarcoma	0.0002	0.00464	CcSEcCtD
Acetylsalicylic acid—Somnolence—Thiotepa—sarcoma	0.000197	0.00458	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Vincristine—sarcoma	0.000197	0.00457	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Thiotepa—sarcoma	0.000195	0.00453	CcSEcCtD
Acetylsalicylic acid—PTGS1—connective tissue—sarcoma	0.000195	0.00183	CbGeAlD
Acetylsalicylic acid—ALB—testis—sarcoma	0.000195	0.00183	CbGeAlD
Acetylsalicylic acid—PTGS2—hematopoietic system—sarcoma	0.000194	0.00182	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—sarcoma	0.000193	0.00449	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mitoxantrone—sarcoma	0.000193	0.00449	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vincristine—sarcoma	0.000193	0.00447	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mitoxantrone—sarcoma	0.000192	0.00445	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—sarcoma	0.000191	0.00443	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Vincristine—sarcoma	0.00019	0.00442	CcSEcCtD
Acetylsalicylic acid—Purpura—Epirubicin—sarcoma	0.000189	0.00438	CcSEcCtD
Acetylsalicylic acid—Shock—Mitoxantrone—sarcoma	0.000189	0.00438	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—sarcoma	0.000188	0.00437	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mitoxantrone—sarcoma	0.000188	0.00436	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mitoxantrone—sarcoma	0.000187	0.00434	CcSEcCtD
Acetylsalicylic acid—PTGS2—connective tissue—sarcoma	0.000187	0.00175	CbGeAlD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—sarcoma	0.000186	0.00432	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mitoxantrone—sarcoma	0.000185	0.0043	CcSEcCtD
Acetylsalicylic acid—ALB—liver—sarcoma	0.000184	0.00173	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Thiotepa—sarcoma	0.000183	0.00425	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000182	0.00422	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—sarcoma	0.000182	0.00421	CcSEcCtD
Acetylsalicylic acid—Anaemia—Etoposide—sarcoma	0.000181	0.00419	CcSEcCtD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—sarcoma	0.000179	0.00168	CbGeAlD
Acetylsalicylic acid—Renal impairment—Doxorubicin—sarcoma	0.000177	0.0041	CcSEcCtD
Acetylsalicylic acid—Urticaria—Thiotepa—sarcoma	0.000176	0.00409	CcSEcCtD
Acetylsalicylic acid—PTGS1—skin of body—sarcoma	0.000176	0.00166	CbGeAlD
Acetylsalicylic acid—Vertigo—Etoposide—sarcoma	0.000176	0.00407	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—sarcoma	0.000175	0.00406	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—sarcoma	0.000175	0.00405	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—sarcoma	0.000172	0.004	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—sarcoma	0.000172	0.00399	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mitoxantrone—sarcoma	0.000171	0.00397	CcSEcCtD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—sarcoma	0.000171	0.0016	CbGeAlD
Acetylsalicylic acid—Somnolence—Mitoxantrone—sarcoma	0.00017	0.00395	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—sarcoma	0.000169	0.00393	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mitoxantrone—sarcoma	0.000169	0.00392	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—sarcoma	0.000169	0.00391	CcSEcCtD
Acetylsalicylic acid—PTGS2—skin of body—sarcoma	0.000168	0.00158	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000168	0.00391	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—sarcoma	0.000166	0.00386	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—sarcoma	0.000165	0.00384	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Thiotepa—sarcoma	0.000164	0.0038	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—sarcoma	0.000162	0.00377	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—sarcoma	0.000161	0.00373	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—sarcoma	0.000159	0.0037	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mitoxantrone—sarcoma	0.000158	0.00367	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—sarcoma	0.000157	0.00365	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—sarcoma	0.000157	0.00365	CcSEcCtD
Acetylsalicylic acid—Pruritus—Thiotepa—sarcoma	0.000157	0.00364	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—sarcoma	0.000156	0.00362	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—sarcoma	0.000156	0.00361	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—sarcoma	0.000154	0.00358	CcSEcCtD
Acetylsalicylic acid—PTGS1—cardiac atrium—sarcoma	0.000154	0.00145	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—sarcoma	0.000153	0.00355	CcSEcCtD
Acetylsalicylic acid—PTGS1—uterus—sarcoma	0.000153	0.00144	CbGeAlD
Acetylsalicylic acid—Urticaria—Mitoxantrone—sarcoma	0.000152	0.00353	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Thiotepa—sarcoma	0.000152	0.00352	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—sarcoma	0.000151	0.0035	CcSEcCtD
Acetylsalicylic acid—CYP2C19—liver—sarcoma	0.000148	0.00139	CbGeAlD
Acetylsalicylic acid—Dizziness—Thiotepa—sarcoma	0.000147	0.00341	CcSEcCtD
Acetylsalicylic acid—PTGS2—uterus—sarcoma	0.000146	0.00137	CbGeAlD
Acetylsalicylic acid—Asthma—Doxorubicin—sarcoma	0.000145	0.00338	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—sarcoma	0.000145	0.00338	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vincristine—sarcoma	0.000145	0.00337	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—sarcoma	0.000142	0.0033	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—sarcoma	0.000142	0.00329	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—sarcoma	0.000141	0.00133	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Mitoxantrone—sarcoma	0.000141	0.00328	CcSEcCtD
Acetylsalicylic acid—Vomiting—Thiotepa—sarcoma	0.000141	0.00328	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—sarcoma	0.00014	0.00325	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—sarcoma	0.00014	0.00325	CcSEcCtD
Acetylsalicylic acid—Rash—Thiotepa—sarcoma	0.00014	0.00325	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Thiotepa—sarcoma	0.00014	0.00325	CcSEcCtD
Acetylsalicylic acid—ABCB1—myometrium—sarcoma	0.00014	0.00131	CbGeAlD
Acetylsalicylic acid—Rash—Dactinomycin—sarcoma	0.000139	0.00322	CcSEcCtD
Acetylsalicylic acid—CYP2C8—testis—sarcoma	0.000137	0.00129	CbGeAlD
Acetylsalicylic acid—PTGS2—lymphoid tissue—sarcoma	0.000136	0.00128	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Vincristine—sarcoma	0.000135	0.00313	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—sarcoma	0.000134	0.00312	CcSEcCtD
Acetylsalicylic acid—ABCB1—embryo—sarcoma	0.000134	0.00126	CbGeAlD
Acetylsalicylic acid—PTGS1—tendon—sarcoma	0.000134	0.00126	CbGeAlD
Acetylsalicylic acid—Nausea—Thiotepa—sarcoma	0.000132	0.00306	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—sarcoma	0.000131	0.00305	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mitoxantrone—sarcoma	0.000131	0.00304	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—sarcoma	0.000131	0.00304	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vincristine—sarcoma	0.00013	0.00302	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—sarcoma	0.00013	0.00301	CcSEcCtD
Acetylsalicylic acid—CYP2C8—liver—sarcoma	0.000129	0.00122	CbGeAlD
Acetylsalicylic acid—PTGS2—tendon—sarcoma	0.000128	0.0012	CbGeAlD
Acetylsalicylic acid—Urticaria—Etoposide—sarcoma	0.000127	0.00294	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—sarcoma	0.000126	0.00293	CcSEcCtD
Acetylsalicylic acid—ABCB1—seminal vesicle—sarcoma	0.000126	0.00118	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Epirubicin—sarcoma	0.000126	0.00292	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vincristine—sarcoma	0.000125	0.0029	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—sarcoma	0.000124	0.00288	CcSEcCtD
Acetylsalicylic acid—PTGS2—bone marrow—sarcoma	0.000124	0.00117	CbGeAlD
Acetylsalicylic acid—Rash—Vincristine—sarcoma	0.000124	0.00288	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vincristine—sarcoma	0.000124	0.00288	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mitoxantrone—sarcoma	0.000122	0.00283	CcSEcCtD
Acetylsalicylic acid—Rash—Mitoxantrone—sarcoma	0.000121	0.0028	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mitoxantrone—sarcoma	0.000121	0.0028	CcSEcCtD
Acetylsalicylic acid—ABCB1—hematopoietic system—sarcoma	0.00012	0.00113	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Etoposide—sarcoma	0.000117	0.00273	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—sarcoma	0.000117	0.00272	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—sarcoma	0.000117	0.00272	CcSEcCtD
Acetylsalicylic acid—Nausea—Vincristine—sarcoma	0.000117	0.00271	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—sarcoma	0.000117	0.00271	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—sarcoma	0.000116	0.0027	CcSEcCtD
Acetylsalicylic acid—CYP2C9—liver—sarcoma	0.000115	0.00108	CbGeAlD
Acetylsalicylic acid—Nausea—Mitoxantrone—sarcoma	0.000114	0.00264	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etoposide—sarcoma	0.000113	0.00262	CcSEcCtD
Acetylsalicylic acid—PTGS1—testis—sarcoma	0.000111	0.00104	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Etoposide—sarcoma	0.000109	0.00253	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—sarcoma	0.000109	0.00252	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—sarcoma	0.000108	0.00251	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—sarcoma	0.000105	0.00245	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—sarcoma	0.000101	0.00235	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—sarcoma	0.000101	0.00235	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—sarcoma	0.000101	0.00234	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—sarcoma	0.000101	0.00233	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—sarcoma	0.0001	0.00233	CcSEcCtD
Acetylsalicylic acid—PTGS2—liver—sarcoma	0.0001	0.000943	CbGeAlD
Acetylsalicylic acid—Vertigo—Epirubicin—sarcoma	9.84e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—sarcoma	9.82e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—sarcoma	9.8e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—sarcoma	9.62e-05	0.00223	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—sarcoma	9.49e-05	0.0022	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—sarcoma	9.47e-05	0.0022	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—sarcoma	9.45e-05	0.00219	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—sarcoma	9.36e-05	0.00217	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—sarcoma	9.32e-05	0.00216	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—sarcoma	9.32e-05	0.00216	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—sarcoma	9.31e-05	0.00216	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—sarcoma	9.1e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—sarcoma	9.09e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—sarcoma	9.07e-05	0.00211	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterus—sarcoma	9.05e-05	0.00085	CbGeAlD
Acetylsalicylic acid—Confusional state—Epirubicin—sarcoma	9.01e-05	0.00209	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—sarcoma	8.94e-05	0.00207	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—sarcoma	8.9e-05	0.00207	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—sarcoma	8.79e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—sarcoma	8.78e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—sarcoma	8.75e-05	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—sarcoma	8.75e-05	0.00203	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—sarcoma	8.72e-05	0.00202	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—sarcoma	8.64e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—sarcoma	8.63e-05	0.002	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—sarcoma	8.63e-05	0.002	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—sarcoma	8.44e-05	0.000792	CbGeAlD
Acetylsalicylic acid—Confusional state—Doxorubicin—sarcoma	8.34e-05	0.00194	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—sarcoma	8.27e-05	0.00192	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—sarcoma	8.14e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—sarcoma	8.1e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—sarcoma	8.07e-05	0.00187	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—sarcoma	8.05e-05	0.000756	CbGeAlD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—sarcoma	7.99e-05	0.00186	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—sarcoma	7.97e-05	0.00185	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—sarcoma	7.94e-05	0.00184	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—sarcoma	7.87e-05	0.00183	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—sarcoma	7.7e-05	0.000723	CbGeAlD
Acetylsalicylic acid—ABCB1—bone marrow—sarcoma	7.68e-05	0.000722	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—sarcoma	7.37e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—sarcoma	7.36e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—sarcoma	7.35e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—sarcoma	7.28e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—sarcoma	7.1e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—sarcoma	6.81e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—sarcoma	6.58e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—sarcoma	6.57e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—ABCB1—testis—sarcoma	6.57e-05	0.000617	CbGeAlD
Acetylsalicylic acid—Pruritus—Epirubicin—sarcoma	6.32e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—ABCB1—liver—sarcoma	6.21e-05	0.000583	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Epirubicin—sarcoma	6.11e-05	0.00142	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—sarcoma	6.09e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—sarcoma	5.91e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—sarcoma	5.85e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—sarcoma	5.68e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—sarcoma	5.66e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—sarcoma	5.63e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—sarcoma	5.63e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—sarcoma	5.47e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—sarcoma	5.31e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—sarcoma	5.26e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—sarcoma	5.21e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—sarcoma	5.21e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—sarcoma	4.91e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—sarcoma	4.76e-05	0.000447	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KRAS—sarcoma	1.81e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CREB1—sarcoma	1.79e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KIT—sarcoma	1.77e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FOXO1—sarcoma	1.76e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FOXO1—sarcoma	1.76e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—IL2—sarcoma	1.76e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PDGFRB—sarcoma	1.76e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PDGFRB—sarcoma	1.76e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—sarcoma	1.75e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—sarcoma	1.74e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TLE1—sarcoma	1.74e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PDGFRA—sarcoma	1.73e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PDGFRA—sarcoma	1.73e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—sarcoma	1.72e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.72e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KIT—sarcoma	1.7e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CREB1—sarcoma	1.69e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.68e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—sarcoma	1.67e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—sarcoma	1.65e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—SRC—sarcoma	1.64e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MDM2—sarcoma	1.63e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL2—sarcoma	1.63e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KDR—sarcoma	1.63e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CREB1—sarcoma	1.62e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KDR—sarcoma	1.61e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—KRAS—sarcoma	1.61e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—sarcoma	1.6e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—sarcoma	1.6e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—JUN—sarcoma	1.59e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—sarcoma	1.58e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KRAS—sarcoma	1.58e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CTNNB1—sarcoma	1.58e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFC—sarcoma	1.57e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NPM1—sarcoma	1.57e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.57e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.54e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—sarcoma	1.54e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.51e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KIT—sarcoma	1.5e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KIT—sarcoma	1.48e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MDM2—sarcoma	1.48e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—sarcoma	1.47e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—sarcoma	1.46e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KDR—sarcoma	1.46e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KDR—sarcoma	1.46e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—sarcoma	1.44e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO2—sarcoma	1.43e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CREB1—sarcoma	1.43e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—SRC—sarcoma	1.43e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.43e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HBA1—sarcoma	1.42e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—JUN—sarcoma	1.42e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	1.42e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CREB1—sarcoma	1.41e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CTNNB1—sarcoma	1.41e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MDM2—sarcoma	1.4e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—sarcoma	1.37e-05	9.76e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—sarcoma	1.37e-05	9.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.36e-05	9.7e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—KRAS—sarcoma	1.36e-05	9.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.36e-05	9.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO2—sarcoma	1.36e-05	9.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOXO1—sarcoma	1.35e-05	9.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PDGFRB—sarcoma	1.35e-05	9.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.35e-05	9.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—sarcoma	1.34e-05	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KIT—sarcoma	1.34e-05	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KIT—sarcoma	1.34e-05	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—sarcoma	1.34e-05	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—sarcoma	1.34e-05	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—MDM2—sarcoma	1.34e-05	9.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PDGFRA—sarcoma	1.33e-05	9.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—sarcoma	1.32e-05	9.39e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCND1—sarcoma	1.29e-05	9.15e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—JUN—sarcoma	1.28e-05	9.13e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CREB1—sarcoma	1.28e-05	9.09e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CREB1—sarcoma	1.28e-05	9.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—SRC—sarcoma	1.27e-05	9.07e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CTNNB1—sarcoma	1.27e-05	9.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.27e-05	9.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FLT1—sarcoma	1.26e-05	8.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—sarcoma	1.25e-05	8.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	1.24e-05	8.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PLCG1—sarcoma	1.23e-05	8.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—sarcoma	1.23e-05	8.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—sarcoma	1.22e-05	8.7e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—sarcoma	1.22e-05	8.7e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.22e-05	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PLCG1—sarcoma	1.21e-05	8.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—JUN—sarcoma	1.21e-05	8.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.21e-05	8.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CTNNB1—sarcoma	1.2e-05	8.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.19e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCR4—sarcoma	1.19e-05	8.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MDM2—sarcoma	1.18e-05	8.41e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KRAS—sarcoma	1.18e-05	8.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ATF1—sarcoma	1.17e-05	8.34e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MDM2—sarcoma	1.17e-05	8.31e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—sarcoma	1.16e-05	8.23e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—sarcoma	1.16e-05	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—sarcoma	1.16e-05	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PLCG1—sarcoma	1.15e-05	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—SRC—sarcoma	1.15e-05	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO2—sarcoma	1.14e-05	8.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HBA1—sarcoma	1.13e-05	8.03e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—sarcoma	1.12e-05	7.98e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—sarcoma	1.12e-05	7.95e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—sarcoma	1.11e-05	7.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CXCR4—sarcoma	1.11e-05	7.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.09e-05	7.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—SRC—sarcoma	1.09e-05	7.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.07e-05	7.61e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MDM2—sarcoma	1.06e-05	7.52e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MDM2—sarcoma	1.06e-05	7.52e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—sarcoma	1.06e-05	7.52e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—sarcoma	1.06e-05	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—sarcoma	1.05e-05	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—SRC—sarcoma	1.05e-05	7.43e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—sarcoma	1.04e-05	7.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KIT—sarcoma	1.03e-05	7.34e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—sarcoma	1.03e-05	7.34e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCND1—sarcoma	1.03e-05	7.33e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—JUN—sarcoma	1.03e-05	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CTNNB1—sarcoma	1.02e-05	7.25e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCND1—sarcoma	1.02e-05	7.24e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—JUN—sarcoma	1.02e-05	7.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.01e-05	7.19e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—sarcoma	1.01e-05	7.18e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CTNNB1—sarcoma	1.01e-05	7.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—sarcoma	1.01e-05	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—sarcoma	1e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CREB1—sarcoma	9.83e-06	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—sarcoma	9.82e-06	6.98e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—sarcoma	9.82e-06	6.98e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLCG1—sarcoma	9.64e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—sarcoma	9.54e-06	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—sarcoma	9.53e-06	6.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—sarcoma	9.44e-06	6.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—sarcoma	9.44e-06	6.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO2—sarcoma	9.25e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SRC—sarcoma	9.22e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—sarcoma	9.21e-06	6.55e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—sarcoma	9.21e-06	6.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1R—sarcoma	9.2e-06	6.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO2—sarcoma	9.2e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HBA1—sarcoma	9.19e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—JUN—sarcoma	9.19e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—JUN—sarcoma	9.19e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—sarcoma	9.16e-06	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HBA1—sarcoma	9.14e-06	6.5e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—sarcoma	9.12e-06	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—sarcoma	9.12e-06	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SRC—sarcoma	9.11e-06	6.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—sarcoma	9.01e-06	6.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.98e-06	6.39e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—sarcoma	8.98e-06	6.39e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—sarcoma	8.97e-06	6.38e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—sarcoma	8.88e-06	6.31e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—sarcoma	8.87e-06	6.31e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—sarcoma	8.77e-06	6.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FOXO1—sarcoma	8.76e-06	6.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PDGFRB—sarcoma	8.74e-06	6.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—sarcoma	8.65e-06	6.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PDGFRA—sarcoma	8.61e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—sarcoma	8.47e-06	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—sarcoma	8.26e-06	5.88e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO2—sarcoma	8.26e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SRC—sarcoma	8.24e-06	5.86e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SRC—sarcoma	8.24e-06	5.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HBA1—sarcoma	8.2e-06	5.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FOXO1—sarcoma	8.17e-06	5.81e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—sarcoma	8.17e-06	5.81e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PDGFRB—sarcoma	8.16e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MDM2—sarcoma	8.13e-06	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—sarcoma	8.1e-06	5.76e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—sarcoma	8.08e-06	5.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO2—sarcoma	8.06e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PDGFRA—sarcoma	8.03e-06	5.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—sarcoma	8.03e-06	5.71e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—sarcoma	8.03e-06	5.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HBA1—sarcoma	8.01e-06	5.7e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—sarcoma	7.99e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—sarcoma	7.93e-06	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—sarcoma	7.93e-06	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLCG1—sarcoma	7.85e-06	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLCG1—sarcoma	7.8e-06	5.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—sarcoma	7.66e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—sarcoma	7.63e-06	5.43e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—sarcoma	7.55e-06	5.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO2—sarcoma	7.53e-06	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HBA1—sarcoma	7.48e-06	5.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—sarcoma	7.38e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—sarcoma	7.38e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—sarcoma	7.36e-06	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—sarcoma	7.32e-06	5.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—sarcoma	7.26e-06	5.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KDR—sarcoma	7.25e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—sarcoma	7.22e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—sarcoma	7.22e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JUN—sarcoma	7.07e-06	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—sarcoma	7.01e-06	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLCG1—sarcoma	7e-06	4.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLCG1—sarcoma	6.84e-06	4.86e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—sarcoma	6.82e-06	4.85e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—sarcoma	6.82e-06	4.85e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—sarcoma	6.78e-06	4.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—sarcoma	6.67e-06	4.75e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—sarcoma	6.49e-06	4.62e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—sarcoma	6.41e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SRC—sarcoma	6.39e-06	4.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLCG1—sarcoma	6.39e-06	4.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREB1—sarcoma	6.35e-06	4.52e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SRC—sarcoma	6.34e-06	4.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—sarcoma	6.23e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—sarcoma	6.22e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—sarcoma	6.15e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—sarcoma	6.1e-06	4.34e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—sarcoma	6.06e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—sarcoma	6.06e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREB1—sarcoma	5.93e-06	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—sarcoma	5.8e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—sarcoma	5.8e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—sarcoma	5.56e-06	3.95e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—sarcoma	5.29e-06	3.76e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—sarcoma	5.26e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—sarcoma	5.25e-06	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—sarcoma	4.9e-06	3.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—sarcoma	4.7e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—sarcoma	4.7e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—sarcoma	4.58e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—sarcoma	4.57e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—sarcoma	4.53e-06	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—sarcoma	4.5e-06	3.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—sarcoma	4.46e-06	3.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—sarcoma	4.23e-06	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—sarcoma	4.1e-06	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—sarcoma	3.99e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—sarcoma	3.94e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—sarcoma	3.82e-06	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—sarcoma	3.68e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—sarcoma	3.67e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—sarcoma	3.59e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—sarcoma	3.43e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—sarcoma	3.39e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—sarcoma	3.35e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—sarcoma	3.17e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—sarcoma	3.02e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—sarcoma	2.88e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—sarcoma	2.69e-06	1.91e-05	CbGpPWpGaD
